Xie Sheng

Dr. Xie Sheng

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
LLLiqun Li
Liqun Li
JTJinjing Tan
Jinjing Tan
LLLijian Liu
Lijian Liu
JLJianfeng Li
Jianfeng Li
GCGuangwen Chen
Guangwen Chen
XSXie Sheng
Xie Sheng
Objective: Systematic reviews and meta-analyses have revealed the associations betweenH. pyloriinfection and various health outcomes. We aimed to evaluate the strength and breadth of evidence on the associations.Design: Umbrella review of systematic reviews and meta-analyses.Setting: No settings.Participants: No patients involved.Data sources: Embase, PubMed, Web of Science, Cochrane Library Databases, CNKI, VIP database and Wangfang database from inception to February 1, 2019.Outcomes measures: Diverse diseases (such as cancer and ischaemic heart disease).Results: Sixty articles reporting 88 unique outcomes met the eligible criteria. 74 unique outcomes had nominal significance (p75%). Moreover, 20% exhibited publication bias (p<0.1). In addition, 97% of the methodological qualities were rated ‘critically low’. 36% of the evidence qualities of outcomes were rated ‘low’, 56% of the evidence qualities were rated ‘very low’ and 8% of the evidence qualities were rated ‘moderate’.H. pyloriinfection may be associated with an increased risk of five diseases and a decreased risk of irritable bowel syndrome.Conclusion: Although 60 meta-analyses explored 88 unique outcomes, moderate quality evidence only existed for six outcomes with statistical significance.H. pyloriinfection may be associated with a decreased risk of irritable bowel syndrome and an increased risk of hypertriglyceridemia, chronic cholecystitis and cholelithiasis, gestational diabetes mellitus, gastric cancer and systemic sclerosis.Trial registration: CRD42019124680.

30 December 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
JTJinJing Tan
JinJing Tan
LLLiqun Li
Liqun Li
XHXiaoyan Huang
Xiaoyan Huang
CYChengning Yang
Chengning Yang
XLXue Liang
Xue Liang
XSXie Sheng
Xie Sheng
Objective: Numerous meta-analyses have revealed the association between gastro-oesophageal reflux disease (GORD) and a range of diseases; however, the certainty of the evidence remains unclear. This study aimed to summarise and assess the certainty of evidence derived from meta-analyses. Methods: Embase, PubMed, Web of Science, Cochrane Databases of Systematic Reviews, CNKI and Wangfang databases from their inception to 22 February 2020 were queried for systematic reviews and meta-analyses on the association between GORD and various diseases. The methodological quality of the included studies was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2), and evidence certainty was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. Statistical analysis was conducted using Stata V.15. Results: Ten publications with associations between GORD and different types of diseases were included. There was high heterogeneity (I 2 >75%) among seven independent meta-analyses. Evidence for publication bias in two independent meta-analyses was also observed. According to the AMSTAR 2 approach, the methodological quality was high for 20% of meta-analyses, moderate for 10%, low for 40% and critically low for 30%. Based on GRADE approach, the certainty of evidence was high for the association between GORD and higher risk of chronic obstructive pulmonary disease (COPD) exacerbation (OR 5.37; 95% CI 2.71 to 10.64) and higher prevalence of oesophageal adenocarcinoma (OR 4.57; 95% CI 3.89 to 5.36), and it was moderate for the association between GORD and higher chronic rhinosinusitis prevalence (OR 2.16; 95% CI 1.37 to 3.48). Conclusion: The association between GORD and a range of diseases was extensively studied, and our findings revealed a high certainty of evidence of the association between GORD and an increased risk of COPD exacerbation as well as increased prevalence of oesophageal adenocarcinoma. Further investigations using systematic reviews and meta-analyses of high methodological quality that include prospective large cohort studies and adjusted confounders are warranted. PROSPERO registration number: CRD42019122264.

8 August 2025 in Hereditas
Verified
Journal Article
Open access
JYJing Yan
Jing Yan
YPYifeng Pan
Yifeng Pan
CCChaoqi Chen
Chaoqi Chen
LLLijian Liu
Lijian Liu
JTJinjing Tan
Jinjing Tan
XSXie Sheng
Xie Sheng
Background: Sepsis is frequently combined with acute liver failure (ALF), a critical determinant in the mortality of septic patients. Pyroptosis is a significant form of programmed cell death that plays an important role in the inflammatory response. Research has been conducted to elucidate the relationship between pyroptosis, sepsis, and ALF, but the mechanism of action remains unclear. Methods: Datasets relating to sepsis and ALF were obtained from the Gene Expression Omnibus (GEO). The intersection of differentially expressed genes (DEGs) and pyroptosis-related genes for sepsis and ALF was identified. Simultaneously, a gene diagnosis model for sepsis and ALF was developed using machine learning, and the model’s accuracy was assessed through the plotting of the ROC curves and confusion matrix. The Hub genes identified by the model with an area under the curve (AUC) value ≥ 0.7 were used for the investigation of immune cell infiltration to explain the molecular mechanism of sepsis combined with ALF. The precise mechanism of action of these model genes in sepsis combined with ALF was evaluated through animal experiments. Results: Machine learning revealed that GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF. The examination of immune cell infiltration indicated that immune dysregulation is present in both sepsis and ALF and preliminarily suggested that GABARAP and ITCH may be pivotal in cellular immunity responses, particularly those mediated by T cells. Animal experiments further validated that in the process of sepsis combined with ALF, the expression level of GABARAP is elevated, while the expression level of ITCH is diminished. Conclusions: We found GABARAP and ITCH may serve as diagnostic biomarkers for pyroptosis in sepsis combined with ALF, suggesting their potential involvement in the initiation and advancement of sepsis combined with ALF through cellular immunomodulatory pathways. Clinical trial number: Not applicable.

30 May 2025 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
LLLijian Liu
Lijian Liu
JXJieru Mm Xie
Jieru Mm Xie
JPJin Chan Peng
Jin Chan Peng
GCGuangwen Mm Chen
Guangwen Mm Chen
XSXie Sheng
Xie Sheng
The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.

13 February 2026 in Medicine
Verified
Journal Article
Open access
LLLiqun Li
Liqun Li
LLLijian Liu
Lijian Liu
JYJing Yan
Jing Yan
JTJinjing Tan
Jinjing Tan
XSXie Sheng
Xie Sheng
The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran Q test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted Helicobacter pylori urea antibody levels (odds ratios [ORs] = 1.070, 95% confidence interval [CI]: 1.009–1.134, P = .024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR = 1.071, 95% CI: 1.012–1.134, P = .018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR = 0.830, 95% CI: 0.690–0.999, P = .048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations. H pylori urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.

30 December 2025 in Tissue and Cell
Verified
Journal Article
Closed access
JYJing Yan
Jing Yan
YPYifeng Pan
Yifeng Pan
ZLZhu Liu
Zhu Liu
YCYulin Chen
Yulin Chen
KHKai Hu
Kai Hu
XSXie Sheng
Xie Sheng